Navigation Links
Biostar Pharmaceuticals, Inc. Expands Rural Network by Over 21% in Third Quarter 2010; Brings Total Number of Locations to 8,500
Date:10/25/2010

nese consumers have access to our products and our brand awareness continues to grow. Expanded rural distribution, coupled with strong growth in existing markets, makes us confident in reaching our 2010 sales and net income guidance of $80 million and $18 million, respectively."

About Biostar Pharmaceuticals, Inc.

Biostar Pharmaceuticals, Inc., through its wholly-owned subsidiary and controlled affiliate in China, develops, manufactures and markets pharmaceutical and health supplement products for a variety of diseases and conditions. The Company's most popular product is its Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter ("OTC") medicine for chronic hepatitis B, a disease affecting approximately 10% of the Chinese population. In addition to its hepatitis product, Biostar currently manufactures two broad-based OTC products, two prescription-based pharmaceuticals, one medical device and five health supplements.

Safe Harbor

Certain statements in this release concerning our future growth prospects are forward-looking statements, within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended, which involve a number of risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements. The risks and uncertainties relating to these statements include, but are not limited to, risks and uncertainties regarding the success of our investments, risks and uncertainties regarding fluctuations in earnings, our ability to sustain our previous levels of profitability including on account of our ability to manage growth, intense competition, wage increases in China, our ability to attract and retain highly skilled professionals, time and cost overruns on fixed-price, fixed-time frame contracts, client concentration, our ability to successfully complete and integrate potential acquisitions, withdrawal o
'/>"/>

SOURCE Biostar Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Biostar Pharmaceuticals, Inc. Reports Record Revenues and Earnings for 2008
2. Biostar Pharmaceuticals, Inc. Reports Continued Revenues and Earnings Growth in First Quarter of 2009
3. Biostar Pharmaceuticals, Inc. Retains HC International, Inc. to Implement Investor Relations Program
4. Biostar Pharmaceuticals, Inc. to Host Fiscal Year 2009 Second Quarter Earnings Conference Call on Friday, August 14, 2009 at 10:30 a.m. EDT
5. Biostar Pharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results
6. Biostar Pharmaceuticals, Inc. to Launch Xin Aoxing Oleanolic Acid Capsules in Beijing and Shanghai
7. Biostar Pharmaceuticals, Inc. Announces First Quarter 2010 Financial Results
8. Biostar Pharmaceuticals, Inc. Begins Assembly of New Production Line
9. Biostar Pharmaceuticals, Inc. Appoints New Chief Financial Officer
10. Keryx Biopharmaceuticals, Inc. to Hold Conference Call on Second Quarter 2008 Financial Results on Monday, August 11, at 8:30 A.M. EDT
11. VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
(Date:10/20/2014)... PureTech , a science and technology development ... today the closing of a $55 million growth ... a $120 Billion group of funds. The funding ... forward and to advance new healthcare related products ... really go for the big ideas that can ...
(Date:10/19/2014)... Latin American hardware encryption display market report defines and ... forecast of revenue. This market was valued at $165.0 ... million by 2018, at a CAGR of 70.3% from ... the Latin American hardware encryption market report to get ... provides a glimpse of the segmentation of the market, ...
Breaking Biology Technology:aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3
... 28 /PRNewswire-Asia-FirstCall/ -- NeoStem, Inc. (NYSE Amex:, NBS ) ("NeoStem" or ... China , announced that the Company,s Director,of Clinical Affairs and Apheresis, ... the American Society for Apheresis (ASFA) 2010 Annual,Meeting on Friday, May ... , ...
... ,, NEW YORK , ... ) ("NeoStem" or the "Company"), an international biopharmaceutical,company with operations ... Company has,been invited to present its adult stem cell technologies ... in New York City on, June 1, 2010 ...
... producer to distribute Hamilton Thorne,s laser products in North America , ... TSX VENTURE: HTL , ... TORONTO , May 27 /PRNewswire-FirstCall/ - Hamilton ... for the stem cell research and fertility clinic markets, today announces a vendor ...
Cached Biology Technology:NeoStem Selected to Present at American Society for Apheresis 2NeoStem Selected to Present at American Society for Apheresis 3NeoStem Selected to Present at American Society for Apheresis 4NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 2NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 3NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 4NeoStem's Advanced Adult Stem Cell Technology to be Featured at Upcoming Conference 5Hamilton Thorne partners with Leica Microsystems 2Hamilton Thorne partners with Leica Microsystems 3Hamilton Thorne partners with Leica Microsystems 4
(Date:10/15/2014)... 44th Rosenstiel Award for Distinguished Work in Biomedical Science ... mechanisms of genomic instability and its implications for the ... alumnus to win the Rosenstiel Award; the first, Rod ... is the Charles A. Janeway Professor of Pediatrics and ... investigator at the Howard Hughes Medical Institute at Boston ...
(Date:10/14/2014)... A new study published in Cancer Research ... liver and colon cancers—can promote the development of skin ... proliferation and survival of sun-damaged skin cells. , Previously ... seven proteins called sirtuins that help regulate genomic stability ... aging. SIRT6 helps repair DNA damage, which can lead ...
(Date:10/14/2014)... is how to produce enough food to feed the ... Agriculture Organization of the United Nations predicts that food ... to feed a growing global population, and plants are ... production. Plants—grains, cereals, fruits, vegetables, and more—feed humans ... must tap into our knowledge of how plants work ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
... the John Innes Centre have provided a new solution to an ... their parents. In a study to be published online next week ... researchers found a type of genetic "noise" caused by a surprising ... in closely related species. They found that when species hybridise, some ...
... a first-of-its kind map that details the height of the ... canopy maps, the new map is the first that spans ... map, based on data collected by NASA,s ICESat, Terra, and ... much carbon the world,s forests store and how fast that ...
... This press release is available in French . ... a lower risk of developing cancer, according to a study carried ... Centre hospitalier de l,Universit de Montral, and McGill University. The findings, ... show that male eczema sufferers had a lower risk of lung ...
Cached Biology News:What causes hybrid vigor? 2First-of-its-kind map details the height of the globe's forests 2Asthma and eczema sufferers have a lower risk of developing a cancer 2
Image Acquisition and documentation system for fluorescent and non-fluorescent gels, membranes, blots, film, plates and assays...
... features a 4.1 mega pixel digital color ... TLC color images., The cabinet features ... longwave UV tubes positioned on two sides ... fluorescence studies , Interior overhead white ...
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
... thermoactive designer enzyme that enables RT-PCR ... PCR enzyme allows reverse transcription and ... elevated temperatures (65C), which helps to ... and results in highly stringent, accurate ...
Biology Products: